Kidney Failure Chronic
📧 Sign up to get email alerts when something new happens for Kidney Failure Chronic.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-04EMA Authorised: Silapo (epoetin zeta) — Stada Arzneimittel AG
The EMA authorises Silapo (epoetin zeta) by Stada Arzneimittel AG for treating anemia associated with cancer, chronic kidney failure, and bl…
-
EMA approval · 2026-07-20EMA Authorised: Retacrit (epoetin zeta) — Pfizer Europe MA EEIG
Authorised status for Retacrit (epoetin zeta) by EMA for use in anemia-related indications, including kidney failure, cancer-related anemia,…
-
EMA approval · 2020-11-25EMA Authorised: Silapo (epoetin zeta) — Stada Arzneimittel AG
Silapo (epoetin zeta) has been authorised by the EMA for indications related to anemia associated with chronic kidney disease, cancer, and u…